Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis
暂无分享,去创建一个
R F Schinazi | T. Chou | R. Schinazi | T C Chou | A. Nahmias | R T Scott | X J Yao | A J Nahmias | R. T. Scott | X. Yao
[1] M. Hirsch,et al. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. , 1981, The New England journal of medicine.
[2] F. Valeriote,et al. Synergistic interaction of anticancer agents: a cellular perspective. , 1975, Cancer chemotherapy reports.
[3] T. Chou,et al. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. , 2005, European journal of biochemistry.
[4] D. J. Bauer,et al. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group , 1978, Nature.
[5] E. Kern,et al. Alteration of Mortality and Pathogenesis of Three Experimental Herpesvirus hominis Infections of Mice with Adenine Arabinoside 5′-Monophosphate, Adenine Arabinoside, and Phosphonoacetic Acid , 1978, Antimicrobial Agents and Chemotherapy.
[6] Seymour S. Cohen,et al. Aranucleosides and aranucleotides in viral chemotherapy. , 1979, Pharmacology & therapeutics.
[7] A. Frydén,et al. ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS Randomised Multicentre Study in Consecutive Swedish Patients , 1984, The Lancet.
[8] L. Crane,et al. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice , 1984, Antimicrobial Agents and Chemotherapy.
[9] Y. Cheng,et al. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates , 1985, Antimicrobial Agents and Chemotherapy.
[10] R. Schinazi,et al. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds. , 1982, The American journal of medicine.
[11] R. Schinazi,et al. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus , 1983, Antimicrobial Agents and Chemotherapy.
[12] R. Schooley,et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. , 1986, The New England journal of medicine.
[13] T. Chou,et al. Distribution, Metabolism, and Excretion of 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)thymine and 1-(2-Fluoro-2-deoxy-β-d-arabinofuranosyl)-5-iodocytosine , 1983 .
[14] F. Aoki,et al. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine , 1985, Antimicrobial Agents and Chemotherapy.
[15] T. Chou,et al. Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats. , 1981, Cancer research.
[16] T. Chou,et al. Comparison of dose-effect relationships of carcinogens following low-dose chronic exposure and high-dose single injection: an analysis by the median-effect principle. , 1980, Carcinogenesis.
[17] R. Schinazi,et al. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice , 1982, Antimicrobial Agents and Chemotherapy.
[18] S. Soong,et al. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. , 1983, Pediatrics.
[19] D. Pavan-Langston,et al. Effect of combined acyclovir and vidarabine on infection with herpes simplex virus in vitro and in vivo. , 1984, The Journal of infectious diseases.
[20] D. Nelson,et al. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[21] T. Chou,et al. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.
[22] E. Kieff,et al. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. , 1968, The Journal of general virology.
[23] T. Chou,et al. Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. , 1976, Journal of theoretical biology.